Flag­ship woos an­oth­er Big Phar­ma BD ex­ec to biotech. Red blood cell ther­a­pies any­one?

Flag­ship Pi­o­neer­ing — which has built a rep­u­ta­tion for stock­ing its port­fo­lio com­pa­nies with Big Phar­ma vets — has raid­ed J&J again for a deal­mak­er.

Most re­cent­ly, Jim Jogerst was se­nior di­rec­tor of busi­ness de­vel­op­ment at Janssen’s in­fec­tious dis­eases and vac­cines busi­ness. He will now be­come Ru­bius Ther­a­peu­tics’ chief busi­ness of­fi­cer, tasked with iden­ti­fy­ing part­ner­ships, col­lab­o­ra­tions and al­liances, ac­cord­ing to CEO Pablo Cagnoni.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER